Executive announcements: Civco, Confirma, Swissray

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Civco Medical Solutions has appointed Geoffrey Dalbow as chief technology officer. Dalbow will oversee oncology solution development initiatives at Civco and assist in the facilitation of new oncology opportunities. He will be responsible for managing Civco’s clinical advisory board to support research and product development efforts for the oncology business solutions, as well as assessing opportunities for additional mergers and acquisitions. 

Dalbow is a clinical medical physicist with extensive experience in the research and development of solutions for the detection and diagnosis of cancer. In his career Dalbow has directed several research and development efforts for a broad range of products and solutions to improve cancer care. He comes to Civco from Philips Medical Systems where he was recently employed as the director of research development and marketing for Philips Medical Systems-Oncology.

Confirma has appointed Ward Sparacio as vice president of sales. Prior to joining Confirma, Ward Sparacio was director of sales for ultrasound vendor SonoSite. Ward managed SonoSite’s $100 million domestic sales organization, as well as clinical operations and administrative functions. He will report to Dan Bickford, executive vice president of sales and marketing.

Swissray International Inc. appointed Gina Raimondo and Dr. Floyd D. Loop to its board of directors.

Raimondo is a general partner of Point Judith Capital. Gina leads the firm's healthcare investing, with a focus on medical device and healthcare information technology companies. She represents Point Judith on the boards of GetWellNetwork, Afferent, Spirus Medical, MedOptions, and Novare Surgical.

Loop was the CEO and chairman of the board of governors of The Cleveland Clinic Foundation from 1989-2004. Earlier, he chaired the Department of Thoracic and Cardiovascular Surgery at the Cleveland Clinic from 1975 - 1989. Loop and his colleagues were responsible for today's widespread use of arterial conduits in coronary artery surgery, innovations in valve repair, reoperations and numerous changes in technical procedure. As a surgeon, Loop performed more than 12,000 open heart operations and authored 350 papers on all aspects of cardiovascular surgery. He has served as president of the American Association for Thoracic Surgery, chairman of the Residency Review Committee, and as a member of the American Board of Thoracic Surgery.